Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IsoClear is a private South African medical device company focused on commercializing and distributing ophthalmology and selected surgical products. The company positions itself as a customer-centric healthcare supplier serving surgeons and facilities with devices intended to improve surgical outcomes and patient quality of life. Its portfolio appears concentrated in eye care, including cataract, retina, refractive visualization, glaucoma, and dry eye offerings, alongside a dermatology/plastics electrosurgery line. Rather than a drug-development biotech model, IsoClear operates as a commercial-stage medtech distributor and supplier representing third-party manufacturers in South Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IsoClear.